Page 40 - Anjali Singh

Affordable mass electric vehicles key to unlocking demand in Indian market

A compact, budget-friendly electric car from a major Indian manufacturer, could be the tipping point for widespread EV adoption

Metropolis Healthcare revenue up 17%, targets industry-leading growth

In Q4, the business-to-consumers (B2C) revenues grew by approximately 20 per cent Y-o-Y, and revenues from the Mumbai market also saw 20 per cent growth

JK Tyre & Industries Q4 results: Net profit rises 56.2% to Rs 169 cr

The tyre maker remains optimistic about the tyre demand outlook, driven by robust infrastructure spending and buoyant economic activities

Eris Lifesciences Q4 results: Net profit rises 8.41% to Rs 70.9 crore

On a sequential basis, the company exhibited a 13.2 per cent increase in revenue; however, the PAT declined by 30.96 per cent

Dermatology segment in IPM poised for 11- 12% growth amid rising demand

The increasing incidence of skin diseases and the growing awareness about these conditions among the Indian populace have been pivotal in driving the dermatology market's expansion

Tyre manufacturers Ceat and Apollo to hike prices as input costs soar

Crude prices, which hovered around $88 to 90 over the past three months, represent a 6 to 8 per cent increase from the previous quarter, adding further strain on manufacturers' margins

JB Pharma aims to grow its revenue by 12-14% in the next two years

JB Pharma plans to maintain its presence in cardiology, focusing on hypertension, heart failure, and lipid-lowering treatments

JB Pharma Q4 results: Net profit soars 43% to Rs 126 cr, revenue up 13%

For the full year of FY24, JB Pharma posted an 11 per cent Y-o-Y increase in revenue and a 35 per cent increase in PAT, reaching Rs 3,484 crore and Rs 553 crore respectively

SII to acquire 20% stake in needle-free tech company IntegriMedical

The collaboration leverages SII's manufacturing and distribution strength with IntegriMedical's innovative technology

Zydus Lifesciences Q4 results: Profit rises four-fold to Rs 1,179 crore

On a sequential basis, the company exhibited a 22.83 per cent increase in revenue, the PAT also rose by 53.57 per cent

Zydus, MSN partner to license, supply affordable cancer tablets in the US

MSN Lab will manufacture and supply Cabozantinib; Zydus will handle marketing, distribution and sales

GSK's Shingrix vaccine can prevent shingles for over a decade: Study

Shingles is a painful rash caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Up to one in three people will develop shingles in their lifetime

Zydus Wellness Q4 profit up 3.4%, driven by strong brand performance

For the full year of FY24, the company posted a 14 per cent Y-o-Y decline in PAT and the revenue grew by 3.2 per cent reaching Rs 266.9 crore and Rs 2,327.8 crore respectively

Eicher Motors' Q4 PAT rises 18%, Royal Enfield sales hit record high

On a sequential basis, the company's PAT rose 7.48%, while the revenue rose by 1.85%

Piramal Pharma Q4 profit Jumps 102% to Rs 101.3 cr, FY24 revenue Up 18%

On a sequential basis, the company's profit jumped more than nine-fold

Ceat plans to revamp brand strategy to target SUV owners, adventure bikers

Ceat plans to reach its target audience through various touchpoints

Dr Lal PathLabs Q4 results: Net profit jumps 49% to Rs 84.5 crore

Eyes expansion into Tier 3 and Tier 4 towns

Cipla Q4 results: Net profit soars 79% on strong India and US business

Eyes further market expansion and partnerships in FY25

AstraZeneca to withdraw Covid-19 vaccine Vaxzevria globally on weak demand

AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe

ICRA forecasts moderate growth for tyre sector in FY25 as input costs rises

The report cites healthy demand from OEMs in the passenger vehicle (PV) and two-wheeler (2W) segments, along with replacement demand, as the primary drivers of domestic growth